RVEc vaccine (USAMRIID)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRVEc vaccine (USAMRIID)
Drug Alias NameRTA-1-33/44-198RTA 1-33/44-198/Alhydrogel
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoisoning
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUS Army Medical Research Institute of Infectious Diseases
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUS Army Medical Research Institute of Infectious Diseases
Active IndicationsN/A
Inactive IndicationsPoisoning

Other Information

ATC CodeN/A
Related LinksN/A